论文部分内容阅读
目的观察低分子肝素对肝癌患者栓塞化疗的增效作用。方法观察30例肝癌行管肝动脉栓塞化疗(transcatheter arterialchemoembolization,TACE)及应用低分子肝素患者的近期疗效、血小板、APTT及PT,并与27例单纯TACE的患者做对照。结果低分子肝素组肝癌患者近期疗效显著优于对照组(P<0.05),低分子肝素组肝癌患者血小板轻度减少、APTT、PT轻度延长,但没有统计学意义(P>0.05)。结论对TACE患者应用低分子肝素安全且有增效作用。
Objective To observe the synergistic effect of low molecular weight heparin on chemoembolization in patients with liver cancer. Methods Thirty patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization (TACE) and short-term therapeutic effect of low molecular weight heparin, platelets, APTT and PT were observed and compared with 27 patients with TACE alone. Results The short-term curative effect of LMWH group was significantly better than that of the control group (P <0.05). The platelet count of patients with LMWH was slightly decreased, while the APTT and PT were slightly prolonged. However, there was no statistical significance (P> 0.05). Conclusion The application of low molecular weight heparin in TACE patients is safe and synergistic.